Section
Highlight Rheumatologic diseases—including rheumatoid arthritis, systemic lupus erythematosus, spondyloarthropathies, vasculitides, and connective tissue disorders—represent a...
Mayo Clinic leads U.S. News’ 2025-2026 rankings for gastroenterology and GI surgery, reflecting excellence in outcomes, capabilities, and research. This review examines the clinical context, ranking methodology, and relevance for clin
A critical analysis of the 2025–2026 U.S. News rankings for diabetes and endocrinology care, examining methodology, clinical impact, and implications for patient care and referral.
A new, function-driven definition of “clinical obesity” dramatically lowers global obesity prevalence rates compared to BMI-based estimates, raising implications for disease surveillance, prevention, and healthcare policy.
Massachusetts General Hospital leads the 2025-2026 US News psychiatric hospital rankings. Rankings highlight excellence in psychiatric care, but methodological nuances and clinical implications warrant closer examination.
CKD-associated pruritus affects up to 85% of dialysis patients and significantly impairs quality of life. Stepwise management, including novel therapies like nemolizumab, is essential for effective symptom control and improved patient outco
Longitudinal data from CARDIA reveal declining physical activity before and after CVD events, with pronounced disparities among Black women, highlighting the need for targeted interventions across the life course.
A large US trial shows that intensive, structured lifestyle programs yield greater cognitive improvement in at-risk older adults compared to self-guided approaches, though both are beneficial.
New research shows walking 7,000 steps daily offers substantial health benefits, debunking the long-held belief in the 10,000-step rule.
Community-based data suggest lecanemab is safe and effective for early-stage Alzheimer’s, with manageable ARIA rates and infusion reactions, particularly in ApoE4 noncarriers.
A large phase 3 trial reveals that structured, multidomain lifestyle interventions significantly improve cognition in older adults at risk for cognitive decline, outperforming self-guided strategies.
New Alzheimer’s Association guidelines endorse blood-based biomarkers as diagnostic adjuncts, not standalone tests, emphasizing rigorous clinical evaluation and high test accuracy.
Overdose deaths from synthetic opioids alone in U.S. youth aged 15–24 surged 168% between 2018 and 2022, now representing one-third of all youth OD fatalities. Clinical vigilance, harm reduction, and targeted prevention are urgently needed.
A recent survey found 39% of elective sports surgery patients used CBD for pain or sleep, with one-third reporting benefit—underscoring the need for more evidence and opioid alternatives.
An FDA expert panel debates the risks and benefits of SSRI antidepressants in pregnancy, emphasizing the need to weigh untreated depression risks against potential drug-related fetal outcomes.
Extended daytime naps and inadequate nighttime sleep independently and synergistically elevate the risk of incident atrial fibrillation, according to a large Spanish cohort study.
AI-powered protein design offers a fast, personalized approach to cancer treatment, enhancing immune response and minimizing side effects.
Researchers developed an AI platform designing proteins that direct immune cells to target cancer precisely, accelerating personalized immunotherapy from years to weeks. This breakthrough enables rapid, specific treatments, promising safer,